Search Tag:
#LIVES2021: High-Dose CPFA in Septic Shock Patients. COMPACT-2 Trial
2021 05 Oct
Findings from the COMPACT-2 trial were presented today at #LIVES2020. The study evaluated the efficacy and safety of high dose (> 0.2 L/kg of treated plasma per day) coupled plasma filtration-adsorption (CPFA) in treating patients with septic shock. The study was performed in 12 Italian ICUs and enrolled patients aged 14 or more who were admitted... Read more
2021 RAD-AID Conference on International Radiology and Global Health
2021 06 Nov
Find RAD-AID On Social Media Read more